trending Market Intelligence /marketintelligence/en/news-insights/trending/J7gCdaO0mXL-5cc2KI9B-w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medical device maker CHF Solutions prices $10.8M public offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Medical device maker CHF Solutions prices $10.8M public offering

Medical device company CHF Solutions Inc. has priced an underwritten public offering to raise $10.8 million.

Eden Prairie, Minn.-based CHF, which develops cardiac and coronary disease products, is offering 146,607 class A units at $5.25 apiece. Each unit consists of one share, a series 1 warrant to purchase a share at that price, and a series 2 warrant to purchase a share at the price. The series 1 warrants will expire in five years, and the series 2 warrants will expire either 18 months from the date of the offering, or upon the U.S. Food and Drug Administration's approval of CHF Solutions' Aquadex FlexFlow fluid removal device in pediatric patients.

CHF Solutions is also offering 1,910,536 class B units also at $5.25 apiece. Each class B unit consists of one series G convertible preferred share, which is convertible into one share of common stock, plus a Series 1 warrant to purchase a common share, and a Series 2 warrant to purchase a share.

The offering is expected to close on March 12.

Ladenburg Thalmann & Co. Inc. acted as book-running manager for the offering.